Table 1.
The correlation between the expression of ADCK1 and clinical features.
| Characteristic | Total | ADCK1 expression | χ2 | P-value | |
|---|---|---|---|---|---|
| Low, n = 49 | High, n = 51 | ||||
| Gender | |||||
| Male | 48 | 21 | 27 | 0.313 | 0.326 |
| Female | 52 | 28 | 24 | ||
| Age (years) | |||||
| >60 | 60 | 31 | 29 | 0.514 | 0.327 |
| ≤60 | 40 | 18 | 22 | ||
| Tumor size (cm3) | |||||
| >50 | 17 | 6 | 11 | 1.545 | 0.462 |
| 10–50 | 46 | 24 | 22 | ||
| <10 | 37 | 19 | 18 | ||
| TNM stage | |||||
| I–II | 48 | 32 | 16 | 11.529 | 0.001 |
| III–IV | 52 | 17 | 35 | ||
| Organ metastasis | |||||
| Yes | 31 | 10 | 21 | 5.039 | 0.031 |
| No | 69 | 39 | 30 | ||
| Lymph node metastasis | |||||
| 0 | 11 | 7 | 4 | ||
| 1–5 | 23 | 6 | 17 | ||
| ≥5 | 66 | 36 | 30 | 6.587 | 0.037 |
| AJCC cancer stage, 7th edition | |||||
| I–II | 48 | 32 | 16 | ||
| III–IV | 52 | 17 | 35 | 11.529 | 0.001 |
| Reoccurence | |||||
| Yes | 26 | 10 | 16 | ||
| No | 74 | 39 | 35 | 0.211 | 0.257 |
| Pathologicl grade | |||||
| I, I–II | 97 | 47 | 50 | ||
| II, III | 3 | 2 | 1 | ||
| Chemotherapy regimen | |||||
| XELOX | 53 | 29 | 24 | ||
| FOLFOX | 43 | 16 | 27 | 7.249 | 0.027 |